NASDAQ : INBS

Intelligent Bio Solutions Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 1.83 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.54M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Intelligent Bio Solutions Inc. (INBS) reported revenue of 4.22M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year July - June; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Operating Revenue4.22M4.22M3.05M3.11M1.26M
Revenue4.22M4.22M3.05M3.11M1.26M
Cost of Revenue2.17M2.17M1.81M1.69M930.20K
Gross Profit2.05M2.05M1.25M1.43M326.67K
Selling, General & Admin10.50M10.50M8.92M9.26M8.03M4.92M
Research & Development3.37M3.37M2.40M1.67M507.42K3.85M
Other Operating Expenses-677.78K-677.78K-816.90K-424.78K-737.63K-437.15K
Operating Expenses14.36M14.36M11.71M11.71M8.76M8.34M
Operating Income-12.31M-12.31M-10.46M-10.28M-8.44M-8.34M
Interest Expense-10.74K-10.74K-26.34K-167.14K-223.53K-7.54K
Interest & Investment Income110.33K110.33K101.52K84.82K9.68K14.43K
Currency Exchange Gain (Loss)39.82K39.82K-911.00-1.18K-9.83K-3.99K
Other Non Operating Income (Expenses)175.74K2.15M
EBT Excluding Unusual Items-12.17M-12.17M-10.38M-10.19M-6.51M-8.33M
Impairment of Goodwill-4.16M
Asset Writedown-298.56K-298.56K-220.06K
Pretax Income-12.47M-12.47M-10.60M-10.19M-10.66M-8.33M
Earnings From Continuing Operations-12.47M-12.47M-10.60M-10.19M-10.66M-8.33M
Minority Interest in Earnings37.70K37.70K36.15K34.17K32.84K27.93K
Net Income-12.43M-12.43M-10.57M-10.16M-10.63M-8.31M
Net Income to Common-12.43M-12.43M-10.57M-10.16M-10.63M-8.31M
Shares Outstanding (Basic)1.47M1.47M527.36K159.28K
Shares Outstanding (Diluted)1.47M1.47M527.36K159.28K
EPS (Basic)-8.44-8.44-20.04-63.77
EPS (Diluted)-8.44-8.44-20.04-63.80
Free Cash Flow-12.05M-12.05M-9.91M-9.79M-7.88M-3.74M
Free Cash Flow Per Share-8.18-8.18-18.79-61.48
Gross Margin48.63%48.63%40.85%45.81%25.99%
Operating Margin-292.03%-292.03%-342.64%-330.46%-671.24%
Profit Margin-294.91%-294.91%-346.23%-326.40%-845.89%
Free Cash Flow Margin-285.94%-285.94%-324.62%-314.71%-627.15%
EBITDA-11.15M-11.15M-9.48M-9.31M-7.62M
EBITDA Margin-264.42%-264.42%-299.15%
D&A For EBITDA1.16M1.16M976.42K974.36K814.48K
EBIT-12.31M-12.31M-10.46M-10.28M-8.44M-8.34M
EBIT Margin-292.03%-292.03%
Advertising Expenses725.42K

Balance sheet

Fiscal year July - June; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Cash & Equivalents3.99M3.99M1.02M6.30M1.54M8.24M
Short-Term Investments149.16K149.16K125.69K111.19K118.19K46.60K
Cash & Short-Term Investments4.14M4.14M1.15M6.42M1.66M8.28M
Accounts Receivable848.46K848.46K594.61K429.70K293.86K1.53M
Other Receivables826.03K826.03K1.07M548.64K539.30K436.24K
Receivables1.67M1.67M1.67M978.35K833.16K2.47M
Inventory418.58K418.58K635.22K777.54K979.91K
Prepaid Expenses862.70K862.70K364.04K363.07K359.95K116.53K
Other Current Assets327.50K34.10K
Total Current Assets7.10M7.10M4.14M8.53M3.86M10.87M
Property, Plant & Equipment2.05M2.05M320.85K872.59K1.24M391.41K
Other Intangible Assets2.80M2.80M3.79M4.37M5.26M
Long-Term Accounts Receivable1.09M
Total Assets11.94M11.94M8.25M13.78M10.35M12.35M
Accounts Payable712.45K712.45K897.26K602.34K1.20M715.90K
Accrued Expenses2.82M2.82M2.00M1.57M1.56M1.11M
Current Portion of Long-Term Debt197.15K515.28K353.21K
Current Portion of Leases147.00K147.00K84.66K274.83K223.45K
Current Unearned Revenue2.49M2.34M2.84M
Other Current Liabilities1.25M1.25M2.17M208.50K
Total Current Liabilities4.93M4.93M5.35M5.45M5.88M4.66M
Long-Term Debt402.86K
Long-Term Leases1.67M1.67M81.32K356.17K
Long-Term Unearned Revenue1.09M
Pension & Post-Retirement Benefits49.93K49.93K84.92K63.62K24.90K50.63K
Total Liabilities6.65M6.65M5.44M5.60M6.67M5.81M
Common Stock29.06K29.06K7.32K34.56K1.94K7.45K
Additional Paid-In Capital80.99M80.99M65.85M60.97M46.18M38.58M
Retained Earnings-74.96M-74.96M-62.53M-51.96M-41.81M-31.18M
Treasury Stock-1.00-1.00-1.00-1.00-1.00
Comprehensive Income & Other-546.19K-546.19K-327.94K-712.61K-575.50K-788.13K
Total Common Equity5.51M5.51M3.00M8.33M3.80M6.62M
Minority Interest-220.01K-220.01K-182.31K-146.16K-111.99K-79.15K
Shareholders' Equity5.29M5.29M2.81M8.18M3.69M6.55M
Total Liabilities & Equity11.94M11.94M8.25M13.78M10.35M12.35M
Total Debt1.82M1.82M281.81K871.44K1.34M
Net Cash (Debt)2.32M2.32M863.79K5.54M319.75K8.28M
Net Cash Per Share1.581.581.6434.81
Filing Date Shares Outstanding3.03M3.03M897.91K424.97K19.41K
Total Common Shares Outstanding2.91M2.91M732.33K345.59K19.41K
Working Capital2.17M2.17M-1.21M3.08M-2.02M6.20M
Book Value Per Share1.901.904.0924.10195.74
Tangible Book Value2.71M2.71M-794.18K3.96M-1.46M6.62M
Tangible Book Value Per Share0.930.93-1.0811.45-75.04
Machinery116.66K116.66K81.56K63.14K57.76K
Construction In Progress543.41K646.12K391.41K
Leasehold Improvements21.02K21.02K21.82K20.07K20.07K

Cash flow statement

Fiscal year July - June; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Net Income-12.43M-12.43M-10.57M-10.16M-10.63M-8.31M
Depreciation & Amortization1.16M1.16M1.21M1.21M966.73K
Asset Writedown & Restructuring Costs298.56K298.56K220.06K4.16M2.60M
Stock-Based Compensation195.21K195.21K238.04K230.50K260.00K
Provision & Write-off of Bad Debts9.97K9.97K546.006.77K
Other Operating Activities61.34K61.34K-54.33K-163.23K-2.21M-91.05K
Change in Accounts Receivable-253.85K-253.85K-164.91K-135.84K-293.86K
Change in Inventory216.64K216.64K142.32K202.37K-345.39K
Change in Accounts Payable-684.74K-684.74K2.58M-632.95K84.50K242.66K
Change in Other Net Operating Assets-503.21K-503.21K-3.28M-135.51K633.67K2.20M
Operating Cash Flow-11.93M-11.93M-9.68M-9.57M-7.38M-3.36M
Capital Expenditures-125.73K-125.73K-231.84K-221.43K-505.12K-380.22K
Sale of Property, Plant & Equipment40.16K40.16K
Cash Acquisitions-189.02K
Other Investing Activities-500.00K
Investing Cash Flow-85.57K-85.57K-231.84K-221.43K-694.14K-880.22K
Issuance of Common Stock14.98M14.98M4.60M14.56M2.55M
Repurchase of Common Stock-14.41K
Other Financing Activities-1.33M
Financing Cash Flow14.98M14.98M4.60M14.56M1.44M
Foreign Exchange Rate Adjustments1.49K1.49K27.16K-707.00-64.86K-97.13K
Net Cash Flow2.97M2.97M-5.28M4.77M-6.70M-4.34M
Free Cash Flow-12.05M-12.05M-9.91M-9.79M-7.88M-3.74M
Free Cash Flow Margin-285.94%-285.94%-324.62%-314.71%-627.15%
Free Cash Flow Per Share-8.18-8.18-18.79-61.48
Levered Free Cash Flow-6.72M-6.72M-5.80M-5.87M-3.67M-1.56M
Unlevered Free Cash Flow-6.71M-6.71M-5.79M-5.76M-3.53M-1.56M
Change in Working Capital-1.23M-1.23M-720.78K-701.93K78.92K2.44M

Ratios

Fiscal year July - June; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Market Capitalization5.03M5.49M11.89M5.98M6.47M9.86M
Enterprise Value2.70M265.26K9.42M-2.61M5.71M-968.30K
Last Close Price1.762.2917.2019.20333.601,588.80
PS Ratio1.191.303.891.925.15
PB Ratio0.931.044.220.731.761.51
P/TBV Ratio1.852.021.511.49
EV/Sales Ratio0.640.063.094.54
Debt / Equity Ratio0.340.340.100.110.36
Net Debt / Equity Ratio-0.44-0.44-0.31-0.68-0.09-1.27
Net Debt / EBITDA Ratio0.210.210.090.600.04
Net Debt / FCF Ratio0.190.190.090.570.042.22
Asset Turnover0.420.420.280.260.11
Inventory Turnover4.114.112.561.92
Quick Ratio1.181.180.531.360.422.20
Current Ratio1.441.440.771.570.662.33
Return on Equity (ROE)-307.69%-307.69%-192.87%-171.71%-208.44%-77.34%
Return on Assets (ROA)-76.20%-76.20%-59.35%-53.26%-46.44%-30.46%
Return on Capital Employed (ROCE)-175.50%-175.50%-360.80%-123.50%-188.70%-108.40%
Earnings Yield-508.48%-226.46%-88.92%-169.72%-164.21%-84.27%
FCF Yield-239.83%-219.57%-83.37%-163.64%-121.75%-37.92%
Buyback Yield / Dilution-179.27%-179.27%-231.10%